XERIS BIOPHARMA HOLDINGS INC - NOTE 5.000% 7/1

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / NOTE 5.000% 7/1
Principal, excl. options Q3 2024
14.7M
Holdings value Q3 2024
$16.8M
Value change Q3 2024
$0
Grand Portfolio weight change Q3 2024
0%
Number of holders
2
Number of buys Q3 2024
0
Number of sells Q3 2024
0
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $14.7M $16.8M $0 $1.13 2
2024 Q2 $14.7M $15.2M $0 $1.03 2
2024 Q1 $14.7M $15.1M -$18.6K $1.03 2
2023 Q4 $14.7M $15.9M $0 $1.09 3
2023 Q3 $14.7M $14.5M -$36.8M $0.98 3
2023 Q2 $46.7M $53.1M +$480K $1.10 5
2023 Q1 $46.7M $42.6M +$71.6K $0.89 6
2022 Q4 $46.7M $42.9M +$2.17M $0.83 6
2022 Q3 $51.5M $48.4M $0 $0.93 6
2022 Q2 $46.7M $43.3M $0 $0.91 5
2022 Q1 $46.7M $54.6M $0 $1.17 5
2021 Q4 $46.7M $56.9M $0 $1.24 5
2021 Q3 $46.7M $51.9M +$22.4K $1.14 5
2021 Q2 $46.7M $73.7M +$13.1K $1.57 5
2021 Q1 $46.7M $79.1M +$1.54M $1.70 5
2020 Q4 $45.7M $80.1M -$67.8M $1.76 7
2020 Q3 $83.1M $162M +$17.2M $1.94 14
2020 Q2 $81M $80.5M +$80.5M $0.99 21